These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2277587)

  • 21. Capsular polysaccharide antigens for detection of serotype-specific antibodies to Actinobacillus pleuropneumoniae.
    Bossé JT; Johnson RP; Rosendal S
    Can J Vet Res; 1990 Jun; 54(3):320-5. PubMed ID: 2379111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum antibodies to Klebsiella capsular polysaccharides in ankylosing spondylitis.
    Sahly H; Podschun R; Sass R; Bröker B; Kekow J; Gross WL; Ullmann U
    Arthritis Rheum; 1994 May; 37(5):754-9. PubMed ID: 8185704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and immunogenicity of Klebsiella pneumoniae K1 capsular polysaccharide vaccine in humans.
    Cryz SJ; Fürer E; Germanier R
    J Infect Dis; 1985 Apr; 151(4):665-71. PubMed ID: 3882856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants.
    Väkeväinen M; Eklund C; Eskola J; Käyhty H
    J Infect Dis; 2001 Sep; 184(6):789-93. PubMed ID: 11517443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.
    Lin H; Peng Y; Lin Z; Zhang S; Guo Y
    Microb Pathog; 2015; 83-84():35-40. PubMed ID: 25959527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Capsular Polysaccharide (CPS) Release by Serotype 3 Pneumococcal Strains Reduces the Protective Effect of Anti-Type 3 CPS Antibodies.
    Choi EH; Zhang F; Lu YJ; Malley R
    Clin Vaccine Immunol; 2016 Feb; 23(2):162-7. PubMed ID: 26677201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunochemical determination of the configuration of a haptenic substituent.
    Heidelberger M; Kvarnström I; Eriksen J; Nimmich W; Dudman WF
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4244-6. PubMed ID: 6159627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunochemical studies on some serological cross-reactions in the Klebsiella group. 11. Structure of the capsular ploysaccharides of Klebsiella aerogenes strain B. 1076/48 and "Enterobacter" strain 349.
    Eriksen J
    Acta Pathol Microbiol Scand; 1965; 64(4):511-21. PubMed ID: 5318717
    [No Abstract]   [Full Text] [Related]  

  • 29. Structure of the capsular polysaccharide of Klebsiella type 73 (Enterobacter aerogenes).
    Batavyal L; Roy N
    Carbohydr Res; 1981 Dec; 98(1):105-13. PubMed ID: 7317881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiological typing of Enterobacter aerogenes.
    Gaston MA; Strickland MA; Ayling-Smith BA; Pitt TL
    J Clin Microbiol; 1989 Mar; 27(3):564-5. PubMed ID: 2715326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.
    Goyette-Desjardins G; Calzas C; Shiao TC; Neubauer A; Kempker J; Roy R; Gottschalk M; Segura M
    Infect Immun; 2016 Jul; 84(7):2059-2075. PubMed ID: 27113360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Capsular polysaccharide from Mycoplasma mycoides subsp. mycoides shows potential for protection against contagious bovine pleuropneumonia.
    Mwirigi M; Nkando I; Olum M; Attah-Poku S; Ochanda H; Berberov E; Potter A; Gerdts V; Perez-Casal J; Wesonga H; Soi R; Naessens J
    Vet Immunol Immunopathol; 2016 Oct; 178():64-9. PubMed ID: 27496744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ
    J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunochemical relations between pneumococcal group 19 and Klebsiella capsular polysaccharides.
    Lee CJ; Koizumi K
    J Immunol; 1981 Oct; 127(4):1619-23. PubMed ID: 6792279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigenic crossreactivity and lipopolysaccharide neutralization properties of bovine immunoglobulin G.
    Tomita GM; Todhunter DA; Hogan JS; Smith KL
    J Dairy Sci; 1995 Dec; 78(12):2745-52. PubMed ID: 8675757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A murine monoclonal antibody against Klebsiella capsular polysaccharide is opsonic in vitro and protects against experimental Klebsiella pneumoniae infection.
    Trautmann M; Cryz SJ; Sadoff JC; Cross AS
    Microb Pathog; 1988 Sep; 5(3):177-87. PubMed ID: 3063912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of Vi capsular polysaccharide vaccine evaluated for three years in Korea.
    Kim YR; Yoo JH; Hur JK; Kang JH; Shin WS; Kang MW
    J Korean Med Sci; 1995 Oct; 10(5):314-7. PubMed ID: 8750055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Micro-complement fixation in Klebsiella classification.
    Steffen DL; Cocks GT; Wilson AC
    J Bacteriol; 1972 Jun; 110(3):803-8. PubMed ID: 4624110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human monoclonal antibodies to Pseudomonas aeruginosa type-specific lipopolysaccharides, toxin A and Klebsiella capsular polysaccharides.
    Lang AB; Fürer E; Schürch U; Cross AS; Larrick JW; Cryz SJ
    Dev Biol Stand; 1990; 71():121-6. PubMed ID: 1698165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Additional immunochemical relationships of capsular polysaccharides of Klebsiella and pneumococci.
    Heidelberger M; Nimmich W
    J Immunol; 1972 Dec; 109(6):1137-44. PubMed ID: 4404452
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.